v3.26.1
Revenue - Disaggregation of Revenue (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Disaggregation of Revenue [Line Items]        
Net sales $ 5,442 $ 5,061 $ 10,646 $ 9,724
MedSurg        
Disaggregation of Revenue [Line Items]        
Net sales 1,818 1,716 3,519 3,293
Cardiovascular        
Disaggregation of Revenue [Line Items]        
Net sales 3,624 3,345 7,126 6,430
U.S.        
Disaggregation of Revenue [Line Items]        
Net sales 3,426 3,224 6,709 6,185
U.S. | MedSurg        
Disaggregation of Revenue [Line Items]        
Net sales 1,251 1,183 2,398 2,275
U.S. | Cardiovascular        
Disaggregation of Revenue [Line Items]        
Net sales 2,175 2,042 4,311 3,909
Int'l        
Disaggregation of Revenue [Line Items]        
Net sales 2,017 1,837 3,936 3,539
Int'l | MedSurg        
Disaggregation of Revenue [Line Items]        
Net sales 567 534 1,121 1,018
Int'l | Cardiovascular        
Disaggregation of Revenue [Line Items]        
Net sales 1,449 1,303 2,815 2,521
Endoscopy        
Disaggregation of Revenue [Line Items]        
Net sales 793 737 1,529 1,410
Endoscopy | U.S.        
Disaggregation of Revenue [Line Items]        
Net sales 491 456 937 876
Endoscopy | Int'l        
Disaggregation of Revenue [Line Items]        
Net sales 303 281 593 534
Urology        
Disaggregation of Revenue [Line Items]        
Net sales 684 676 1,330 1,310
Urology | U.S.        
Disaggregation of Revenue [Line Items]        
Net sales 503 499 967 967
Urology | Int'l        
Disaggregation of Revenue [Line Items]        
Net sales 181 178 363 342
Neuromodulation        
Disaggregation of Revenue [Line Items]        
Net sales 341 303 659 574
Neuromodulation | U.S.        
Disaggregation of Revenue [Line Items]        
Net sales 257 228 494 432
Neuromodulation | Int'l        
Disaggregation of Revenue [Line Items]        
Net sales 84 75 166 142
Interventional Cardiology & Vascular Therapies        
Disaggregation of Revenue [Line Items]        
Net sales 1,333 1,178 2,577 2,302
Interventional Cardiology & Vascular Therapies | U.S.        
Disaggregation of Revenue [Line Items]        
Net sales 586 499 1,139 966
Interventional Cardiology & Vascular Therapies | Int'l        
Disaggregation of Revenue [Line Items]        
Net sales 746 679 1,438 1,337
Watchman        
Disaggregation of Revenue [Line Items]        
Net sales 507 486 1,014 911
Watchman | U.S.        
Disaggregation of Revenue [Line Items]        
Net sales 459 446 921 836
Watchman | Int'l        
Disaggregation of Revenue [Line Items]        
Net sales 48 40 93 75
Electrophysiology        
Disaggregation of Revenue [Line Items]        
Net sales 916 840 1,821 1,570
Electrophysiology | U.S.        
Disaggregation of Revenue [Line Items]        
Net sales 606 587 1,209 1,099
Electrophysiology | Int'l        
Disaggregation of Revenue [Line Items]        
Net sales 310 252 612 472
Cardiac Rhythm Management        
Disaggregation of Revenue [Line Items]        
Net sales 585 590 1,163 1,168
Cardiac Rhythm Management | U.S.        
Disaggregation of Revenue [Line Items]        
Net sales 349 355 698 713
Cardiac Rhythm Management | Int'l        
Disaggregation of Revenue [Line Items]        
Net sales 236 235 465 455
Interventional Oncology & Embolization        
Disaggregation of Revenue [Line Items]        
Net sales 283 251 551 479
Interventional Oncology & Embolization | U.S.        
Disaggregation of Revenue [Line Items]        
Net sales 175 155 344 296
Interventional Oncology & Embolization | Int'l        
Disaggregation of Revenue [Line Items]        
Net sales $ 108 $ 96 $ 207 $ 183